Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine in Childhood Autism
NCT00252603Phase 3Completed
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Apr 2004
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of galantamine in Autism Spectrum Disorder (ASD), sponsored by University of Medicine and Dentistry of New Jersey. Started Apr 2004; status: completed.
02
Drugs
galantamine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00252603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252603.